| Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic … T Vos, RM Barber, B Bell, A Bertozzi-Villa, S Biryukov, I Bolliger, ... The lancet 386 (9995), 743-800, 2015 | 7063 | 2015 |
| Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of … S Abdalla, F Abd-Allah, MI Abdel Aziz The Lancet, 2015 | 3333 | 2015 |
| Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic … GBD 2015 Risk Factors Collaborators Lancet (London, England) 388 (10053), 1659, 2016 | 2962 | 2016 |
| The global burden of cancer 2013 C Fitzmaurice, D Dicker, A Pain, H Hamavid, M Moradi-Lakeh, ... JAMA oncology 1 (4), 505-527, 2015 | 2775 | 2015 |
| Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of … M Correction Naghavi, H Wang, R Lozano, A Davis, X Liang, M Zhou, ... The Lancet 385 (9963), 117-171, 2015 | 1348 | 2015 |
| Cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life years for 29 cancer groups from 2010 to 2019: a systematic analysis … JM Kocarnik, K Compton, FE Dean, W Fu, BL Gaw, JD Harvey, ... JAMA oncology 8 (3), 420-444, 2022 | 995 | 2022 |
| The global, regional, and national burden of pancreatic cancer and its attributable risk factors in 195 countries and territories, 1990–2017: a systematic analysis for the … A Pourshams, SG Sepanlou, KS Ikuta, C Bisignano, S Safiri, G Roshandel, ... The lancet Gastroenterology & hepatology 4 (12), 934-947, 2019 | 789* | 2019 |
| The global burden of cancer attributable to risk factors, 2010–19: a systematic analysis for the Global Burden of Disease Study 2019 KB Tran, JJ Lang, K Compton, R Xu, AR Acheson, HJ Henrikson, ... The Lancet 400 (10352), 563-591, 2022 | 397 | 2022 |
| Global, regional, and national burden of brain and other CNS cancer, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 AP Patel, JL Fisher, E Nichols, F Abd-Allah, J Abdela, A Abdelalim, ... The Lancet Neurology 18 (4), 376-393, 2019 | 371 | 2019 |
| Trends in the prevalence of diabetes and impaired fasting glucose in association with obesity in Iran: 2005–2011 A Esteghamati, K Etemad, J Koohpayehzadeh, M Abbasi, A Meysamie, ... Diabetes research and clinical practice 103 (2), 319-327, 2014 | 312 | 2014 |
| Pearls and pitfalls in clinical interpretation of prostate-specific membrane antigen (PSMA)-targeted PET imaging S Sheikhbahaei, A Afshar-Oromieh, M Eiber, LB Solnes, MS Javadi, ... European journal of nuclear medicine and molecular imaging 44, 2117-2136, 2017 | 259 | 2017 |
| Population-level risks of alcohol consumption by amount, geography, age, sex, and year: a systematic analysis for the Global Burden of Disease Study 2020 D Bryazka, MB Reitsma, MG Griswold, KH Abate, C Abbafati, ... The Lancet 400 (10347), 185-235, 2022 | 229 | 2022 |
| FDG-PET/CT and MRI for evaluation of pathologic response to neoadjuvant chemotherapy in patients with breast cancer: a meta-analysis of diagnostic accuracy studies S Sheikhbahaei, TJ Trahan, J Xiao, M Taghipour, E Mena, RM Connolly, ... The oncologist 21 (8), 931-939, 2016 | 192 | 2016 |
| Imaging of nonprostate cancers using PSMA-targeted radiotracers: rationale, current state of the field, and a call to arms RAS Fragomeni, T Amir, S Sheikhbahaei, SC Harvey, MS Javadi, ... Journal of Nuclear Medicine 59 (6), 871-877, 2018 | 137 | 2018 |
| The global burden of adolescent and young adult cancer in 2019: a systematic analysis for the Global Burden of Disease Study 2019 EM Alvarez, LM Force, R Xu, K Compton, D Lu, HJ Henrikson, ... The Lancet Oncology 23 (1), 27-52, 2022 | 119 | 2022 |
| The value of FDG PET/CT in treatment response assessment, follow-up, and surveillance of lung cancer S Sheikhbahaei, E Mena, A Yanamadala, S Reddy, LB Solnes, ... American Journal of Roentgenology 208 (2), 420-433, 2017 | 118 | 2017 |
| The global, regional, and national burden of oesophageal cancer and its attributable risk factors in 195 countries and territories, 1990–2017: a systematic analysis for the … F Kamangar, D Nasrollahzadeh, S Safiri, SG Sepanlou, C Fitzmaurice, ... The lancet Gastroenterology & hepatology 5 (6), 582-597, 2020 | 109 | 2020 |
| Diagnostic accuracy of follow-up FDG PET or PET/CT in patients with head and neck cancer after definitive treatment: a systematic review and meta-analysis S Sheikhbahaei, M Taghipour, R Ahmad, C Fakhry, AP Kiess, CH Chung, ... American Journal of Roentgenology 205 (3), 629-639, 2015 | 105 | 2015 |
| Prostate-specific membrane antigen (PSMA)-targeted PET imaging of prostate cancer: an update on important pitfalls S Sheikhbahaei, RA Werner, LB Solnes, KJ Pienta, MG Pomper, ... Seminars in nuclear medicine 49 (4), 255-270, 2019 | 97 | 2019 |
| An inverse association between serum vitamin D levels with the presence and severity of impaired nerve conduction velocity and large fiber peripheral neuropathy in diabetic … A Alamdari, R Mozafari, A Tafakhori, S Faghihi-Kashani, N Hafezi-Nejad, ... Neurological Sciences 36, 1121-1126, 2015 | 89 | 2015 |
